Jason Adair
Corporate Officer/Principal en Liquidia Technologies, Inc. .
Fortuna: 1 M $ al 31/05/2024
Perfil
Jason Adair's current job is Vice President-Corporate Development & Strategy at Liquidia Technologies, Inc. He started this position in 2016.
Mr. Adair's former job was Executive Director-Corporate Development at BioCryst Pharmaceuticals, Inc. He held this position from 2011 to 2015.
He also worked as Vice President-Corporate Development & Strategy at Liquidia Corp.Mr. Adair's education includes an undergraduate degree from Wake Forest University and an MBA from Tuck School of Business at Dartmouth.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
LIQUIDIA CORPORATION
0.15% | 03/06/2024 | 112 465 ( 0.15% ) | 1 M $ | 31/05/2024 |
Cargos activos de Jason Adair
| Empresas | Cargo | Inicio |
|---|---|---|
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Corporate Officer/Principal | 14/01/2016 |
Antiguos cargos conocidos de Jason Adair.
| Empresas | Cargo | Fin |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/12/2015 |
| LIQUIDIA CORPORATION | Contacto de Relaciones con Inversores | - |
Formación de Jason Adair.
| Wake Forest University | Undergraduate Degree |
| Tuck School of Business at Dartmouth | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
| LIQUIDIA CORPORATION | Health Technology |
| Empresas privadas | 1 |
|---|---|
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Health Technology |
- Bolsa de valores
- Insiders
- Jason Adair
